Want to see GB:JDG full AI Analyst Report?
Top Page
Judges Scientific
(LSE:JDG)
Select Model
Select Model
Rating:54Neutral
Price Target:
4,386.00 p
â–²(8.30% Upside)
Action:Reiterated
Date:08/06/26
The score is anchored by solid underlying business growth and reliable cash generation, but is pulled down by weaker 2025 profitability and a moderately leveraged balance sheet. Technicals are notably bearish with the stock trading below major moving averages, and valuation remains stretched at ~55x earnings despite a ~2.5% dividend yield.
Positive Factors
Revenue Growth
Sustained multi-year revenue expansion demonstrates widening market penetration across the group's niche instrument franchises. Durable top-line growth provides scope to fund R&D, aftermarket services and acquisitions, supporting long-term cash generation and resilience versus cyclicality.
Negative Factors
Profitability Decline
A sharp drop in net income and swinging margins reduce earnings quality and predictability. Over the medium term this weakens retained earnings available for reinvestment or debt reduction and raises the importance of margin recovery for sustainable returns.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Sustained multi-year revenue expansion demonstrates widening market penetration across the group's niche instrument franchises. Durable top-line growth provides scope to fund R&D, aftermarket services and acquisitions, supporting long-term cash generation and resilience versus cyclicality.
Read all positive factors
Judges Scientific (JDG) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£273.42M
Dividend Yield2.8%
Average Volume (3M)17.29K
Price to Earnings (P/E)50.1
Beta (1Y)0.74
Revenue Growth9.13%
EPS Growth-47.18%
CountryUK
Employees791
SectorTechnology
Sector Strength88
IndustryHardware, Equipment & Parts
Share Statistics
EPS (TTM)0.82
Shares Outstanding6,660,695
10 Day Avg. Volume26,976
30 Day Avg. Volume17,290
Financial Highlights & Ratios
PEG Ratio-1.46
Price to Book (P/B)4.53
Price to Sales (P/S)2.60
P/FCF Ratio18.04
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£5,600.00Price Target Upside38.27% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)2
Revenue Forecast (FY)£124.06M
Judges Scientific Business Overview & Revenue Model
Company Description
Judges Scientific plc is a company dedicated to the design, production, and worldwide sale of advanced scientific instruments. Its operations are structured around two core divisions: Materials Sciences and Vacuum. The company provides a wide arra...
How the Company Makes Money
Judges Scientific makes money primarily through revenue generated by its operating subsidiaries that sell specialized scientific instruments, equipment, and associated solutions to research and industrial customers. Key revenue streams typically i...
Judges Scientific Financial Statement Overview
Summary
Income Statement
64
Positive
Balance Sheet
58
Neutral
Cash Flow
62
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 145.80M | 133.60M | 136.10M | 113.21M | 91.29M |
| Gross Profit | 101.00M | 92.00M | 93.60M | 21.01M | 15.34M |
| EBITDA | 32.10M | 30.90M | 32.20M | 29.00M | 20.33M |
| Net Income | 5.50M | 10.40M | 9.50M | 12.50M | 12.68M |
Balance Sheet | |||||
| Total Assets | 188.10M | 205.10M | 183.50M | 185.79M | 88.98M |
| Cash, Cash Equivalents and Short-Term Investments | 19.40M | 17.90M | 13.70M | 20.83M | 18.41M |
| Total Debt | 65.20M | 73.60M | 65.30M | 59.95M | 21.32M |
| Total Liabilities | 104.20M | 117.90M | 100.90M | 131.33M | 45.58M |
| Stockholders Equity | 83.70M | 86.90M | 82.40M | 54.24M | 42.78M |
Cash Flow | |||||
| Free Cash Flow | 21.00M | 22.10M | 20.60M | 12.33M | 13.44M |
| Operating Cash Flow | 26.40M | 28.50M | 26.50M | 20.22M | 16.89M |
| Investing Cash Flow | -7.40M | -22.60M | -25.90M | -50.80M | -5.21M |
| Financing Cash Flow | -17.40M | -1.40M | -7.60M | 31.20M | -8.81M |
Judges Scientific Technical Analysis
Neutral
4050.00
Price Trends
4387.40
Negative
4484.19
Negative
4687.18
Negative
Market Momentum
-73.40
Negative
44.71
Neutral
58.19
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:JDG, the sentiment is Neutral. The current price of 4050 is above the 20-day moving average (MA) of 4045.00, below the 50-day MA of 4387.40, and below the 200-day MA of 4687.18, indicating a neutral trend. The MACD of -73.40 indicates Negative momentum. The RSI at 44.71 is Neutral, neither overbought nor oversold. The STOCH value of 58.19 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GB:JDG.
Judges Scientific Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £3.76B | 50.69 | 8.06% | 1.53% | 4.99% | -24.08% | |
73 Outperform | £49.02M | 3.86 | 22.93% | ― | 136.76% | ― | |
72 Outperform | £762.24M | 26.43 | 9.04% | 1.64% | 4.82% | 17.80% | |
62 Neutral | £329.82M | 81.69 | 3.33% | 0.81% | 12.73% | -26.74% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
57 Neutral | £270.18M | -7.56 | -24.38% | 3.68% | -2.68% | 47.33% | |
54 Neutral | £273.42M | 50.06 | 6.24% | 2.80% | 9.13% | -47.18% |
* Technology Sector Average
GB:JDG
Judges Scientific
4,000.00
-2,210.34
-35.59%
GB:GHH
Gooch & Housego
1,205.00
673.98
126.92%
GB:KMK
Kromek Group plc
7.60
2.70
55.10%
GB:RSW
Renishaw
5,095.00
1,937.37
61.36%
GB:TTG
TT Electronics
163.00
61.80
61.07%
GB:DSCV
discoverIE Group plc
781.00
199.64
34.34%
Judges Scientific Corporate Events
Business Operations and StrategyExecutive/Board ChangesRegulatory Filings and Compliance
Judges Scientific Executives Receive Shares Under Incentive Plan
Positive
Aug 6, 2026
Judges Scientific has reported a series of director and senior management share dealings linked to its Share Incentive Plan. On 5 August 2026, trustees of the plan purchased small volumes of ordinary shares on behalf of several key executives, inc...
Business Operations and StrategyFinancial Disclosures
Judges Scientific Warns on First-Half Weakness but Confirms Full-Year Earnings Targets
Negative
Jul 23, 2026
Judges Scientific plc has reported a markedly weaker first half, with revenue down 21% and order intake 11% lower than the prior year, reflecting the absence of a Geotek coring expedition and uncertainty around U.S. federal research funding. Addit...
Business Operations and StrategyFinancial Disclosures
Judges Scientific Holds FY2026 Outlook as H1 Revenue Drops on Coring and Funding Headwinds
Negative
Jul 23, 2026
Judges Scientific, the acquisitive U.K. scientific instruments group listed on AIM, reported a markedly weaker first half as revenue fell 21% year-on-year amid the absence of a Geotek coring expedition and funding-related softness in U.S. science ...
Dividends
Judges Scientific Executives Reinvest Dividends into Company Shares
Positive
Jul 20, 2026
Judges Scientific has disclosed that Chief Financial Officer Brad Ormsby, together with his spouse, and Non-Executive Deputy Chair Ralph Elman have acquired additional ordinary shares in the company. The purchases were executed on 17 July 2026 thr...
Business Operations and StrategyExecutive/Board Changes
Judges Scientific Executives Add Shares via Incentive Plan
Positive
Jul 9, 2026
Judges Scientific has disclosed that several senior executives, including the chief executive officer, chief financial officer and other key managers, have had ordinary shares purchased on their behalf under the company’s Share Incentive Pla...
Business Operations and StrategyRegulatory Filings and Compliance
Judges Scientific Updates Market on Share Option Scheme Allotments
Neutral
Jun 22, 2026
Judges Scientific plc has provided an update on its share option schemes under the AIM Rules, detailing movements in its long-standing blocklisting arrangements for ordinary shares. The company reported that during the period from 21 December 2025...
Business Operations and Strategy
Judges Scientific Appoints RSM UK as New External Auditor
Neutral
Jun 19, 2026
Judges Scientific plc has appointed RSM UK Audit LLP as its external auditor for the financial year ending 31 December 2026, following an extensive tender process. The change follows the resignation of BDO UK LLP, which had served as auditor since...
Business Operations and Strategy
Judges Scientific Executives Receive Shares Under Incentive Plan
Positive
Jun 11, 2026
Judges Scientific has disclosed a series of small share purchases in its own stock for senior executives, including the chief executive, chief financial officer and other key managers. The transactions involve ordinary shares acquired on 5 June 20...
Regulatory Filings and Compliance
Judges Scientific Updates Share Capital and Voting Rights
Neutral
Jun 1, 2026
Judges Scientific plc has confirmed that, as of 30 May 2026, its total issued share capital stands at 6,660,695 ordinary shares of 5p each, all of which carry one vote per share and none of which are held in treasury. This updated share count sets...
Business Operations and Strategy
Judges Scientific Buys Shares to Satisfy Employee Reward Awards
Positive
May 26, 2026
Judges Scientific plc has acquired 443 ordinary shares of 5p each at a price of 4,650p per share and immediately allocated them to certain employees. The purchase was made to satisfy awards under the company’s reward scheme, underlining its ...
Business Operations and StrategyExecutive/Board ChangesDividendsFinancial DisclosuresShareholder Meetings
Judges Scientific AGM backs all resolutions despite auditor vote dissent
Positive
May 20, 2026
Judges Scientific plc, a specialist consolidator in the scientific instrument industry, operates a portfolio of 25 primarily UK-based businesses whose products are sold worldwide into academic, research and industrial markets. The group targets gl...
Business Operations and Strategy
Judges Scientific Executives Receive Shares Under Incentive Plan
Positive
May 11, 2026
Judges Scientific has disclosed a series of small share purchases under its Share Incentive Plan involving several senior executives, including the chief executive, chief financial officer, chief operating officer and other senior managers. Truste...
Other
Judges Scientific discloses share purchase by non-executive director
Neutral
May 8, 2026
Judges Scientific plc, an acquisitive group in the scientific instruments sector, owns 25 predominantly UK-based businesses whose products serve global customers in academia, research, industry and regulatory bodies. The company targets niche mark...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.